CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes President and CEO gave up 139,524 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Research and Development gave up 27,254 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Commercial gave up 32,332 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 40,459 shares (to pay taxes)
- 8-K Event Results of operations
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 4 Grant or award SVP and General Counsel acquired 30,170 shares (grant or award)
- 4 Open-market buy Director bought 27,532 shares at $43.12 ($1,187,235)
- 4 Open-market sale EVP, Commercial sold 72,230 shares at an average $42.18 ($3,046,928)
- 4 Gift EVP, Research and Development gave 24,000 shares (gift)
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 4 Gift Director gave 1,044 shares (gift)
- 4 Open-market sale Director sold 100,000 shares at $43.55 ($4,355,000)
Page 5 of 126 · 2,517 filings